Pancreatic Cancer Research

ResearcherQueen Mary University of LondonActive in the last 2 years

Lauren C. Cutmore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0723-2651; OpenAlex author ID A5040009067. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocom… First author DOI 10.3390/cancers17091534↗
  2. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.02.013↗
  3. Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.02.006↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nicholas Fraser Brown · 3 shared papers, 2020–2025 · strength 0.59
  2. John F. Marshall · 3 shared papers, 2020–2025 · strength 0.59
  3. Yaohe Wang · 2 shared papers, 2020–2025 · strength 0.37
  4. Renato B. Baleeiro · 1 shared paper, 2025 · strength 0.26
  5. Louisa S. Chard Dunmall · 1 shared paper, 2025 · strength 0.26
  6. Zuoyi Zhao · 1 shared paper, 2025 · strength 0.26
  7. John F. Maher · 1 shared paper, 2020 · strength 0.11
  8. Deepak Raj · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.